68Ga-FAPI-46 and 18F-FDG in Advanced Metastatic Pancreatic Cancer

Recently imaging with new PET radiotracers that act as fibroblast activation protein inhibitors (FAPIs) showed promising results in oncology and even nononcology imaging. Here we report a case of advanced pancreatic adenocarcinoma, imaged with both 18F-FDG and 68Ga-FAPI-46 PET/CT scans. The result indicated that imaging with 68Ga-FAPI-46 showed significant improvement in detection of metastases as well as local malignancy recurrence. Moreover, the intensity and SUVs of the lesions were higher in 68Ga-FAPI-46 scan compared with 18F-FDG.
Source: Clinical Nuclear Medicine - Category: Nuclear Medicine Tags: Interesting Images Source Type: research